Timely topics in nutrition: The role of key adipokines in obesity and insulin resistance in cats

Journal of the American Veterinary Medical Association

Volumn 235, Issue 5, 2009, Pages

  Lusby, Angela L ^a   Davis, Jennifer L ^a   Kirk, Claudia A ^a   Bartges, Joseph W ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; HUMAN; INSULIN RESISTANCE; METABOLISM; OBESITY; PHYSIOLOGY;

ADIPOKINES; ADIPONECTIN; ANIMALS; CAT DISEASES; CATS; HUMANS; INSULIN RESISTANCE; LEPTIN; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349923226     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.235.5.518     Document Type: Article

References (73)

1. Anderson R. Obesity in the dog and cat. Vet Annu 1974; 1441:182-186.
2. Lund EM, Armstrong PJ, Kirk CA, et al. Prevalence and risk factors for obesity in adult cats from private US veterinary practices. Int JAppl Res Vet Med 2005;3:88-96.
3. Prahl A, Guptill L, Glickman NW, et al. Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals J Feline Med Surg 2007;9:351-358.
4. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008;37:753-768.
5. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
6. Zhang F, Chen Y, Heiman M, et al. Leptin: structure, function and biology. In: Litwack G, ed. Vitamins and hormones. Vol 71. San Diego: Academic Press Inc, 2005;345-372.
7. Munzberg H, Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005,8:566-570.
8. Oswal A, Yeo GSH. The leptin melanocortin pathway and the control of body weight: Lessons from human and murine genetics. Obes Rev 2007;8:293-306.
9. Horvath TL. Synaptic plasticity in energy balance regulation. Obesity (Silver Spring) 2006;14:228S-233S.
10. Anukulkitch C, Rao A, Dunshea F, et al. A test of the lipostat theory in a seasonal (ovine) model under natural conditions reveals a close relationship between adiposity and melanin concentrating hormone expression. Dottiest Anim Endocrinol 2009;36:138-151.
11. Munzberg H, Bjomholm M, Bates SH, et al. Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 2005;62:642-652.
12. Shimizu H, Oh S, Okada S, et al. Leptin resistance and obesity. EndocrJ 2007;54:17-26.
13. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999;282:1568-1575.
14. Appleton DJ, Rand JS, Sunvold GD. Plasma leptin concentrations in cats: reference range, effect of weight gain and relationship with adiposity as measured by dual energy x-ray absorptiometry. J Feline Med Surg 2000;2:191-199.
15. Backus RC, Havel PJ, Gingerich RL, et al. Relationship between serum leptin immunoreactivity and body fat mass as estimated by use of a novel gas-phase Fourier transform infrared spectroscopy deuterium dilution method in cats. Am J Vet Res 2000;61:796-801.
16. Park S, Hong SM, Sung SR, et al. Long-term effects of central leptin and resistin on body weight, insulin resistance, and f}-cell function and mass by the modulation of hypothalamic leptin and insulin signaling. Endocrinology 2008;149:445-454.
17. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999;48:1270-1274.
18. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003;111:121-124.
19. Dyck DJ, Heigenhauser GJF, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol 2006;186:5-16.
20. Sell H, Dietze-Schroeder D, Eckel J. The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab 2006;17:416-422.
21. Benomar Y, Wetzler S, Larue-Achagiotis C, et al. In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus. Mol Cell Endocrinol 2005;242:59-66.
22. Ceddia RB, Koistinen HA, Zierath JR, et al. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002;16:1163-1176.
23. Martin LJM, Siliart B, Dumon HJW, et al. Spontaneous hormonal variations in male cats following gonadectomy. J Feline Med Surg 2006;8:309-314.
24. Hoenig M, Thomaseth K, Waldron M, et al. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 2007;292:R227-R234.
25. Appleton DJ, Rand JS, Sunvold GD. Plasma leptin concentrations are independently associated with insulin sensitivity in lean and overweight cats. J Feline Med Surg 2002;4:83-93.
26. Backus RC, Cave NJ, Keisler DH. Gonadectomy and high dietary fat but not high dietary carbohydrate induce gains in body weight and fat of domestic cats. Br J Nutr 2007;98:641-650.
27. Belsito KR, Vester BM, Keel T, et al. Impact of ovariohysterectomy and food intake on body composition, physical activity, and adipose gene expression in cats. J Anim Sci 2009;87:594-602.
28. Kanchuk ML, Backus RC, Calvert CC, et al. Neutering induces changes in food intake, body weight, plasma insulin and leptin concentrations in normal and lipoprotein lipase-deficient male cats. J Nutr 2002;132:1730S-1732S.
29. Hoenig M, Ferguson DC. Effects of neutering on hormonal concentrations and energy requirements in male and female cats. Am J Vet Res 2002;63:634-639.
30. Coenen KR, Gruen ML, Chait A, et al. Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 2007;56:564-573.
31. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
32. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-2355.
33. Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS Lett 2008;582:117-131.
34. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
35. Ryden M, Arner R Tumour necrosis factor-alpha in human adipose tissue-from signalling mechanisms to clinical implications. J Intern Med 2007;262:431-438.
36. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor- alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
37. Miller C, Bartges J, Cornelius L, et al. Tumor necrosis factor- alpha levels in adipose tissue of lean and obese cats. ] Nutr 1998;128:2751S-2752S.
38. Hoenig M, McGoldrick JB, deBeer M, et al. Activity and tissue- specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats. Domest Anim Endocrinol 2006;30:333-344.
39. Peraldi P, Xu M, Spiegelman BM. Thiazolidinediones block tumor necrosis factor-alpha induced inhibition of insulin signaling. J Clin Invest 1997;100:1863-1869. (Pubitemid 27431346)
40. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008;37:635-646.
41. Kim KY, Kim JK, Jeon JH, et al. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF- alpha in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2005;327:460-467.
42. Kita A, Yamasaki H, Kuwahara H, et al. Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem Biophys Res Commun 2005;331:484-490.
43. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
44. Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 2008;6:87-102.
45. Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003;52:1655-1663.
46. Waki H, Yamauchi T, Kamon J, et al. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2005;146:790-796.
47. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidin- edione-mediated improvement in insulin sensitivity. J Biol Chem 2004;279:12152-12162.
48. Fisher FF, Trujillo ME, Hanif W, et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diobetologia 2005;48:1084-1087.
49. Matsuzawa Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005;6:7-14.
50. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
51. Kantartzis K, Fritsche A, Tschritter O, et al. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res 2005;13:1683-1691.
52. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-243.
53. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-1133.
54. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. lancet 2002;360:57-58.
55. Yamamoto Y, Hirose H, Saito I, et al. Adiponectin, an adipocyte- derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004;89:87-90.
56. Snehalatha C, Mukesh B, Simon M, et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003;26:3226-3229.
57. Karbowska J, Kockan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol 2006;57:103-113.
58. Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-953.
59. Combs TP, Berg AH, Obici S, et al. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001;108:1875-1881.
60. Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 2009;296:E22-E36.
61. Rogers QR, Morris JG, Freedland RA. Lack of hepatic enzymatic adaptation to low and high levels of dietary protein in the adult cat. Enzyme 1977;22:348-356.
62. Zoran DL. The carnivore connection to nutrition in cats. J Am Vet Med Assoc 2002;221:1559-1567.
63. Ishioka K, Omachi A, Sasaki N, et al. Feline adiponectin: molecular structures and plasma concentrations in obese cats. J Vet Med Sci 2009;71:189-194.
64. Zini E, Linscheid P, Franchini M, et al. Partial sequencing and expression of genes involved in glucose metabolism in adipose tissues and skeletal muscle of healthy cats. Vet J 2009;180:66-70.
65. Hemandez-Morante JJ, Milagro FI, Larque E, et al. Relationship among adiponectin, adiponectin gene expression and fatty acids composition in morbidly obese patients. Obes Surg 2007; 17:516-524.
66. Lihn AS, Bruun JM, He G, et al. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9-15.
67. Fisher FM, McTernan PG, Valsamakis G, et al. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm Metab Res 2002;34:650-654.
68. Claessens M, van Baak MA, Monsheimer S, et al. The effect of a low-fat, high-protein or high-carbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors. Int J Obes 2009;33:296-304.
69. Riera-Guardia N, Rothenbacher D. The effect of thiazolidin- ediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab 2008;10:367-375.
70. Hoenig M, Ferguson DC. Effect of darglitazone on glucose clearance and lipid metabolism in obese cats. Am J Vet Res 2003;64:1409-1413.
71. Lusby A, Kirk C. Obesity. In: Bonagura J, Twedt DC, eds. Kirk's current veterinary therapy XIV. Philadelphia: Saunders, 2008;191-195.
72. Scarlett JM, Donoghue S. Associations between body condition and disease in cats. J Am Vet Med Assoc 1998;212:1725-1731.
73. Buffington CA. External and internal influences on disease risk in cats. J Am Vet Med Assoc 2002;220:994-1002.